SMS Pharmaceuticals Quarterly Results for Trading Insights
SMSPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹25 Cr
QSept 2025
SMS Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹244 Cr in Sept 2025 (-2.4% vs Mar 2025, +23.2% vs Sept 2024)
- Net Profit of ₹25 Cr in Sept 2025 (+25.0% vs Mar 2025, +78.6% vs Sept 2024)
- EBITDA of ₹50 Cr in Sept 2025 (+19.0% vs Mar 2025)
- Operating Margin of 20.0% in Sept 2025 (+4.0pp vs Mar 2025)
- Earnings Per Share of ₹2.84 in Sept 2025 (+18.3% vs Mar 2025)
SMS Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 244 | 250 | 197 | 214 | 198 | -2.4% | 23.2% |
| Net Profit (₹ Cr) | 25 | 20 | 21 | 24 | 14 | - | - |
| EBITDA (₹ Cr) | 50 | 42 | 40 | 47 | 33 | - | - |
| EPS (₹) | 2.84 | 2.40 | 2.31 | 2.59 | 1.67 | - | - |
| Operating Margin (%) | 20.0% | 16.0% | 20.0% | 21.0% | 16.0% | - | - |
SMS Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize SMS Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for SMS Pharmaceuticals
Additional stock information and data for SMSPHARMA
Revenue Trend (₹ Cr)
Dec 2025
214
Jun 2025
197
Mar 2025
250
Sept 2025
244
Net Profit Trend (₹ Cr)
Dec 2025
24
Jun 2025
21
Mar 2025
20
Sept 2025
25
Operating Margin Trend (%)
Dec 2025
21.0%
Jun 2025
20.0%
Mar 2025
16.0%
Sept 2025
20.0%
Sector Competitors - Quarterly Performance Comparison
Comparing SMS Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹406,351.37 Cr | 1714.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.9 |
|
Divis Laboratories
Sept 2025 |
₹155,471.67 Cr | 5882.0 | 2,860 | 689 | +7.1% | - | 24.1% | 226.5 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹134,945.00 Cr | 4029.2 | 3,219 | 591 | +11.3% | - | 18.4% | 229.7 |
|
Lupin
Sept 2025 |
₹102,578.78 Cr | 2294.1 | 6,921 | 1,485 | +23.2% | - | 21.5% | 70.9 |
|
Dr Reddys Laborator…
Sept 2025 |
₹101,601.09 Cr | 1191.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 73.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores